Download presentation
Presentation is loading. Please wait.
Published byAgus Cahyadi Modified over 6 years ago
1
Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease Randall W. Franz, MD, FACS, RVT, RPVI, Kaushal J. Shah, MD, FACS, RPVI, Richard H. Pin, MD, FACS, RPVI, Thomas Hankins, CCP, Jodi F. Hartman, MS, Michelle L. Wright, MPH Journal of Vascular Surgery Volume 62, Issue 3, Pages (September 2015) DOI: /j.jvs Copyright © 2015 Society for Vascular Surgery Terms and Conditions
2
Fig 1 Flowchart depicts patient accounting. BM-MNC, Bone marrow mononuclear cell. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
3
Fig 2 Kaplan-Meier survivorship curve for the bone marrow mononuclear cell (BM-MNC) implantation procedure using freedom from (a) major amputation, (b) postoperative death, and (c) major amputation and postoperative death as survival end points. Because no major vascular reinterventions were performed after BM-MNC implantation, the survival curve for freedom from amputation also represents major above-ankle amputation survivorship. Journal of Vascular Surgery , DOI: ( /j.jvs ) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.